-
(Research): 1 year full-time; 2 years part-time; IPhD: 5 years full-time; Apply now Overview Overview Our PhD programmes offer training in all aspects of molecular pharmacology and our large internationally
-
analyses carried out by the School of Cancer Sciences. This covers all GCLP aspects of the Translational Pharmacology Laboratory, based at the WWCRC, the GTRF based at the Queen Elizabeth University Hospital
-
common and rare human diseases and regenerative medicine and facilitate development of new therapeutics in molecular pharmacology. We have a breadth of expertise in multi-disciplinary integrative biology
-
: Metabolism is a key determinant of cellular phenotype, amenable to nutritional and/or pharmacological therapeutic interventions. Although the impact of diet and metabolism in homeostatic intestinal stem cell
-
choices: Biomedical Sciences [MSc] , Cardiovascular Sciences [MSc(MedSci)] , Clinical Pharmacology [MSc(MedSci)] , Medical Genetics & Genomics [MSc(MedSci)] , Precision Medicine (with specialisms) [MSc
-
research has focused on acute pharmacological exposure, to single chemicals, in altricial animal models, often only in a single sex. We have developed a unique, more appropriate model, with which
-
, circadian factors in plants structural determination by NMR and X-ray crystallography structural bioinformatics, molecular modelling drug receptors, molecular pharmacology nuclear genomic architecture
-
to highlight how little is known about the anatomical, physiological and pharmacological basis of sensory systems in health and disease. Chronic pain can arise from the skin, from joints or from internal organs
-
established a family of histone demethylases as critical and selective oncogenic factors in AML. Genetic knockdown or pharmacological inhibition of family members was sufficient to induce apoptosis in a broad